Regeneron Pharmaceuticals (REGN) EPS (Diluted)
Regeneron Pharmaceuticals (REGN) reported EPS of $41.48 in fiscal 2025. Since fiscal 2021 ($71.97), it has declined 42%. The high over this period was $71.97, in fiscal 2021.
Free: last 5 years
| Fiscal year | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (Diluted) | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $71.97 | $38.22 | $34.77 | $38.34 | $41.48 |